Sulforaphane (broccoli sprout extract) and autism

What 4 graded rows on sulforaphane (broccoli sprout extract) agree on for autism, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Sulforaphane (broccoli sprout extract) page, with its PubMed record.

Your question

Supplement
Sulforaphane (broccoli sprout extract) Choose another

Sulforaphane (broccoli sprout extract) and autism

4 rows · 513 people

Split. 2 rows found an improvement, 1 found no difference and 1 had mixed results.

No difference or mixed
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.
  • Grade C× 2
  • Grade D× 2
Rows
4
Trials
9
People
513
Pooled reviews may count some twice

Where they differ

From the rows
Trial sizeStudy designWho was studiedGrade

The best-graded row, grade C, is a meta-analysis of 333 people (2025) and found an improvement.

The 2 rows that found an improvement were larger: a median of 189 people, against 28 people for the row that found no difference.

Only the 2 rows that found an improvement include pooled reviews of several trials (1 of 2); the row that found no difference is a single study.

Only the 2 rows that found an improvement name men in their population. Only the row that found no difference names children or teens in its population.

The best grade is C among the rows that found an improvement, and D among the row that found no difference.

1 row with mixed results is left out of this comparison.

The rows

2 improved · 1 no difference · 1 mixed
  1. Grade CSocial responsiveness in autism (pooled) · Improved

    Meta-analysis, 6 studies · n 333 · 2025 · People with autism spectrum disorder (6 placebo-controlled trials)

    As given in each trial · 4–5 and 8–10 weeks (pooled time points)

    Social Responsiveness Scale scores fell more than with placebo at both 4–5 and 8–10 weeks; adverse events did not differ from placebo.

    Row on the Sulforaphane (broccoli sprout extract) page · PubMed 41275316 (opens PubMed)

  2. Grade DAutism behaviour scales in adolescents and young men · Improved

    RCT · n 44 · 2014 · Males aged 13 to 27 with moderate to severe autism spectrum disorder

    50–150 µmol/day · 18 weeks, then 4 weeks off

    Aberrant Behavior Checklist scores fell 34% and Social Responsiveness Scale scores 17% with sulforaphane vs under 3.3% change on placebo; scores rose toward baseline after stopping.

    Row on the Sulforaphane (broccoli sprout extract) page · PubMed 25313065 (opens PubMed)

  3. Grade DAutism behaviour scales in children aged 3–7 · No difference

    RCT · n 28 · 2023 · Children aged 3 to 7 with autism spectrum disorder (Czech Republic)

    Not stated in the abstract · 36 weeks

    ABC, SRS-2 and ADOS-2 scores improved in both groups with no significant difference from placebo at 18 or 36 weeks.

    Row on the Sulforaphane (broccoli sprout extract) page · PubMed 36771424 (opens PubMed)

  4. Grade CAutism behaviour scales in children · Mixed

    RCT · n 108 · 2024 · Children with autism spectrum disorder (multi-centre trial, China)

    Not stated in the abstract · 12 weeks

    Caregiver-rated scales did not differ from placebo; clinician-rated scales improved, and one third of participants had at least a 30% score drop by 12 weeks. Sulforaphane was well tolerated, including in young children.

    Row on the Sulforaphane (broccoli sprout extract) page · PubMed 36427174 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.